XML 66 R59.htm IDEA: XBRL DOCUMENT v3.25.1
Net Loss Per Share Attributable to Adaptive Biotechnologies Corporation Common Shareholders - Computation of the Basic and Diluted Net Loss Per Share Attributable to Common Shareholders (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Earnings Per Share [Abstract]    
Net loss attributable to Adaptive Biotechnologies Corporation $ (29,852) $ (47,507)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic 149,195,028 145,787,527
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, basic $ (0.2) $ (0.33)
Weighted-average shares used in computing net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted 149,195,028 145,787,527
Net loss per share attributable to Adaptive Biotechnologies Corporation common shareholders, diluted $ (0.2) $ (0.33)